GIUSTI, PIETRO
GIUSTI, PIETRO
'Non-narcotic' analgesia in the mouse by transcutaneous electrical stimulation
1978 Giusti, Pietro; Vincenti, E.; Cima, Lorenzo; Giron, G. P.
1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists.
1997 A., Chimirri; G., DE SARRO; A., DE SARRO; R., Gitto; S., Grasso; S., Quartone; M., Zappala; Giusti, Pietro; V., Libri; A., Costanti; A. G., Chapman
[Beta blocking agents in arterial hypertension: 20-year experience].
1988 Casiglia, Edoardo; Gava, R; Giacomello, M; Falliero, E; Cima, L; Giusti, Pietro
[Drug interactions in the treatment of arterial hypertension: an emerging problem].
1987 Casiglia, Edoardo; Gava, R; Giacomello, M; Cima, L; Giusti, Pietro; Pessina, ACHILLE CESARE
[Evaluation of the therapeutic activity and tolerability of difenpiramide in otorhinolaryngology].
1982 Lunghi, F; Blasi, M; Frasson, P; Lunghi, M; Giusti, Pietro
[The physiopathology of opioid peptides].
1982 Giusti, Pietro; Baso, R; Barbuti, Gm; Borin, G; Cima, Lorenzo
A 6-hydroxydopamine in vivo model of Parkinson's disease.
2012 Mercanti, Giulia; Bazzu, G; Giusti, Pietro
A co-ultramicronized N-palmitoylethanolamine/luteolin composite promotes oligodendrocyte precursor cell survival and development and improves outcome in experimental autoimmune encephalomyelitis
2016 Skaper, Stephen D.; Facci, Laura; Barbierato, Massimo; Contarini, Gabriella; Marinelli, Carla; Zusso, Morena; Giusti, Pietro
A co-ultramicronized palmitoylethanolamide/luteolin composite mitigates clinical score and disease-relevant molecular markers in a mouse model of experimental autoimmune encephalomyelitis
2019 Contarini, G.; Franceschini, D.; Facci, L.; Barbierato, M.; Giusti, P.; Zusso, M.
A cost-analysis of hormone therapy in advanced prostate carcinoma: Evidence from Treviso, Italy
2003 Salvato, C.; Terrazzani, G.; Serraglia, D.; Longo, A.; Debetto, Patrizia; Giusti, Pietro; Chinellato, Alessandro
A model of systemic inflammation to study neuroinflammation
2018 Sorrenti, Vincenzo; Giusti, Pietro; Zusso, Morena
A mouse model of high trait anxiety shows reduced heart rate variability that can be reversed by anxiolytic drug treatment
2011 Gaburro, S; Stiedl, O; Giusti, Pietro; Sartori, Sb; Landgraf, R; Singewald, N.
A new place conditioning paradigm to study tolerance to opiates in mice.
1999 Contarino, A.; Drago, F.; A., Zanotti; Natolino, F.; Berti, T.; Giusti, Pietro
A proteomic approach in the study of an animal model of Parkinson's disease
2005 DE IULIIS, A; Grigoletto, Jessica; Recchia, Alessandra; Giusti, Pietro; Arslan, Paola
A sample research of hospitalized acute intoxication cases using an epidemiological form.
1981 Giunta, F; Capuzzo, M; Pizzirani, E; Polato, D; Giron, Gp; Giusti, Pietro; Cima, Lorenzo; Marigo, M.
Abecarnil enhances recovery from diazepam tolerance.
1999 A., Zanotti; Natolino, F; Contarino, A; Lipartiti, M; Giusti, Pietro
Abecarnil, a beta-carboline derivative, does not exhibit anticonvulsant tolerance or withdrawal in mice.
1996 F., Natolino; A., Zanotti; A., Contarino; M., Lipartiti; Giusti, Pietro
Acetylcholinesterase inhibition by tacrine analogues
1997 Piero, Valenti; Angela, Rampa; Alessandra, Bisi; Vincenza, Andrisano; Vanni, Cavrini; Lorena, Fin; LORENA FIN ALESSANDRO, Buriani; Giusti, Pietro
Acetylcholinesterase Inhibitors: Synthesis and Structure-Activity Relationships of omega-[N-Methyl-N-(3-alkylcarbamoyloxyphenyl)-methyl]aminoalkoxyheteroaryl Derivatives.
1998 Rampa, A.; Bisi, A.; Valenti, P.; Recanatini, M.; Cavalli, A.; Andrisano, V.; Cavrini, V.; Fin, L.; Buriani, A.; Giusti, Pietro
Activated carbon as an external antidote: bringing it up to date
1980 Giunta, F.; Visentin, M.; Giusti, Pietro